NCT00235248View on ClinicalTrials.gov

Aortic Arch Related Cerebral Hazard Trial (ARCH)

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

December 31, 2010

Study Completion Date

July 31, 2012

Conditions
Brain InfarctionTransient Ischemic AttackEmbolism
Interventions
DRUG

Warfarin

Warfarin

DRUG

Clopidogrel-aspirin

Clopidogrel-aspirin

Trial Locations (2)

75018

Bichat Hospital Head of Neurology Department, Paris

Vic 3081

National Stroke Research Institute-Austin Health, Heidelberg Heights

Sponsors
All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

Sanofi

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER